- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
Name |
| Ownership Percentage |
| Jurisdiction of Organization |
Alnylam U.S., Inc. |
| 100% |
| Delaware |
Alnylam Securities Corporation |
| 100% |
| Massachusetts |
Sirna Therapeutics, Inc. |
| 100% |
| Delaware |
Alnylam Austria GmbH |
| 100% |
| Austria |
Alnylam Belgium BVBA |
| 100% |
| Belgium |
Alnylam Brasil Farmaceutica Ltda |
| 99% |
| Brazil |
Alnylam (Bermuda) Ltd. |
| 100% |
| Bermuda |
Alnylam Canada ULC |
| 100% |
| Canada |
Alnylam France SAS |
| 100% |
| France |
Alnylam Europe AG |
| 100% |
| Germany |
Alnylam Germany GmbH |
| 100% |
| Germany |
Alnylam Italy Srl |
| 100% |
| Italy |
Alnylam Japan KK |
| 100% |
| Japan |
Alnylam Netherlands BV |
| 100% |
| Netherlands |
Alnylam Pharmaceuticals Spain SL |
| 100% |
| Spain |
Alnylam Sweden AB |
| 100% |
| Sweden |
Alnylam Switzerland GmbH |
| 100% |
| Switzerland |
Alnylam Taiwan Co., Ltd. |
| 100% |
| Taiwan |
ALNYPT Unipessoal Lda |
| 100% |
| Portugal |
Alnylam UK Limited |
| 100% |
| United Kingdom |